Registered entities
GALECTO BIOTECH APS
Reg. No. 34878366Denmark
Galecto Biotech Ab
Reg. No. 556872-8413Sweden
GALECTO, INC.
Reg. No. 1800315United States
Innovation
40 patent families (21 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 3,266 times.
| Year | Filings |
|---|---|
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 10 |
| 2017 | 10 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 13 |
| 2021 | 17 |
| 2022 | 18 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 9 |
Social engagement
Social engagement: 5.4K social following, 2 posts in the last 12 months — top quartile of its industry.
Investor mix
23 investors on record; lead investors include Soleus Capital, Eir Ventures, Ysios Capital, Orbimed; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 57% |
| Private equity | 3 | 13% |
| Accelerator & incubator | 1 | 4% |
| Other / undisclosed | 6 | 26% |
Recent activity
6 Jan 2026
Leadership hire
Chief Operating Officer